International and Fortune 500 clients know who to turn to when facing complex patent litigation or other intellectual property issues. Sal Patel co-chairs Schiff Hardin’s Intellectual Property Group and the Pharmaceuticals and Biologics Patent Litigation Team. Sal is a seasoned trial attorney and has first-chaired more than 10 trials and appeals. He is passionate about implementing creative and scientifically sound arguments for his clients, which have resulted in legal precedent-setting cases.
Sal has served as lead counsel on numerous patent infringement litigation matters, trademark infringement litigation matters, and other commercial disputes.
Sal is effective both in trials and in negotiating favorable settlements for his clients. There are many moving parts in patent litigation, and he is skilled at coordinating multiple parties, experts, and arguments into coherent and persuasive cases. In cases where there are multiple defendants, he represents his clients in a way that makes them stand out from the rest, leading to more favorable results. He also assists companies in Paragraph IV and biosimilars design strategies, helping his clients protect their scientific discoveries.
Sal has represented pharmaceutical companies in many cases involving Paragraph IV disputes and counsels clients on biosimilars. He has also represented clients in patent litigation involving wind and solar technology, medical devices, life sciences, food processing, automotive components, and software, among other sectors.
With a background in chemical engineering, he has significant experience in preparing and prosecuting patent applications in a variety of technologies. Sal also has significant experience with patent and trademark proceedings in the U.S. Patent and Trademark Office.
Clients rely on Sal for intellectual property transactions and licensing, including contracts involving patent, trademark, copyright, and computer and technology law.
In addition to his legal practice, Sal chairs the firm’s Diversity, Equity, and Inclusion Committee.